Arcturus Therapeutics Financial Overview
Arcturus Therapeutics's market cap is currently $242.49M. The company's EPS TTM is $-0.49; its P/E ratio is -4.02; Arcturus Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.79. See an overview of income statement, balance sheet, and cash flow financials.
